SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FiloF who wrote (2039)12/15/2005 8:12:57 PM
From: John McCarthy  Read Replies (1) of 3158
 
Hi -

I posted that because I'm confused ...

(ignoring for a moment that medx ain't interested
in being acquired ..... per your link)

the imclonians on yahoo are hoping for
a buyout from bristol ....

but this particular analyst seems to (and I could be reading
way too much into it) be indicating that bristol's number
one target ain't imclone .... its somebody else ...

moreover, (and this is just my guessing so ignore it)
I think imclone is gonna have a lock on BOTH head and neck
cancer and pancreatic cancer .... by asco we should know for sure ... one via the fda and the other via off-label ... so I just thought imclone would be their natural target ....

anyway ... thats what I was wondering about ... and that
analyst sees it differently ...

regards,
John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext